News & Insight

2 November 2021
Video
Why virtual reality is the future
A short film from Columbia Cancer Research featuring members of our IMAXT team – co-investigators Simon Tavaré and Owen Harris, and postdoctoral researcher Ignacio Vazquez-Garcia. Learn more about the IMAXT team.

Latest

News
25 October 2021
The Cancer Grand Challenges Mutographs team has added an unexpected piece to the complex puzzle surrounding the development of oesophageal squamous…
News
24 October 2021
Oesophageal squamous cell carcinoma (ESCC) is the most common type of oesophageal cancer – a disease that affected more than 600,000 people worldwide…
News
20 October 2021
Surprising discoveries from the Mutographs team challenge the classical view that all carcinogens directly cause mutations and suggest that non-…
News
20 October 2021
Today we launch Discover: a year of scientific creativity – our annual progress magazine showcasing the power of global team science.  Discover …

Latest tweet

Congrats to Barry Stein, patient advocate of our OPTIMISTICC team on receiving the 2021 @CCRAlliance award for Exce… https://t.co/2QT77jZKlr Fri Dec 17 15:05:14 +0000 2021

News and insight archive

Format
Choose
Team
Choose
Tags
Choose
Video
A short film from Columbia Cancer Research featuring members of our IMAXT team – co-investigators Simon Tavaré and Owen Harris, and postdoctoral researcher Ignacio Vazquez-Garcia. Learn more about the IMAXT team.
2 November 2021
News
The Cancer Grand Challenges Mutographs team has added an unexpected piece to the complex puzzle surrounding the development of oesophageal squamous cell carcinoma (ESCC): no mutational signature exists to explain the…
25 October 2021
News
Oesophageal squamous cell carcinoma (ESCC) is the most common type of oesophageal cancer – a disease that affected more than 600,000 people worldwide last year*. Incidence of the disease varies dramatically around the…
24 October 2021
News
Surprising discoveries from the Mutographs team challenge the classical view that all carcinogens directly cause mutations and suggest that non-mutagenic agents play a greater role in tumour promotion than originally…
20 October 2021
News
Today we launch Discover: a year of scientific creativity – our annual progress magazine showcasing the power of global team science.  Discover celebrates how our teams are coming together, thinking differently and…
20 October 2021
News
The SPECIFICANCER team delves deeper into the biological laws that govern tissue specificity in cancer and reveals intricate webs of genetic interactions. This story first featured in our annual progress magazine - …
20 October 2021
News
A new expansion sequencing toolbox and analysis platform from the IMAXT team reveals hidden truths in biology by creating detailed nanoscale-resolution genomic maps. This story first featured in our annual progress…
20 October 2021
News
A deeper understanding of the metabolic changes during tumour development could radically change clinical decision-making and unlock opportunities to intervene across the entire patient journey. This story first…
20 October 2021
News
Chronic inflammation is directly linked to up to 25% of cancer deaths worldwide. Could reprogramming of the inflamed microenvironment prevent, slow or even revert the cascade of inflammation to malignancy?  This story…
20 October 2021